Company: ABBV
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001551152-25-000029
Chunk: 37

Company: AbbVie Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 37
---
 million during the three months ended March 31, 2025 and 5 million shares for $959 million during the three months ended March 31, 2024. AbbVie's remaining stock repurchase authorization was approximately $2.9 billion as of March 31, 2025.Accumulated Other Comprehensive LossThe following table summarizes the changes in each component of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2025:(in millions)Foreign currency translation adjustmentsNet investmenthedging activitiesPension and post-employment benefitsCash flow hedging activitiesTotalBalance as of December 31, 2024$(2,114)$549 $(664)$304 $(1,925)Other comprehensive income (loss) before reclassifications487 (256)(1)(17)213 Net gains reclassified from accumulated other comprehensive loss— (27)(1)(2)(30)Net current-period other comprehensive income (loss)487 (283)(2)(19)183 Balance as of March 31, 2025$(1,627)$266 $(666)$285 $(1,742)Other comprehensive income for the three months ended March 31, 2025 included foreign currency translation adjustments totaling a gain of $487 million principally due to the impact of the strengthening of the Euro on the translation of the company’s Euro-denominated assets and the offsetting impact of net investment hedging activities totaling a loss of $283 million.The following table summarizes the changes in each component of accumulated other comprehensive loss, net of tax, for the three months ended March 31, 2024:(in millions)Foreign currency translation adjustmentsNet investmenthedging activitiesPension and post-employment benefitsCash flow hedging activitiesTotalBalance as of December 31, 2023$(1,106)$65 $(1,488)$224 $(2,305)Other comprehensive income (loss) before reclassifications(396)228 3 44 (121)Net losses (gains) reclassified from accumulated other comprehensive loss— (21)7 (14)(28)Net current-period other comprehensive income (loss)(396)207 10 30 (149)Balance as of March 31, 2024$(1,502)$272 $(1,478)$254 $(2,454)Other comprehensive loss for the three months ended March 31, 2024